產(chǎn)品資料
產(chǎn)品[

HT-29 人結(jié)腸癌細(xì)胞

]資料
如果您對(duì)該產(chǎn)品感興趣的話,可以 sendmsg
產(chǎn)品名稱: HT-29 人結(jié)腸癌細(xì)胞
產(chǎn)品型號(hào): HTB-38
產(chǎn)品廠商: 美國標(biāo)準(zhǔn)生物品收藏中心(ATCC)
產(chǎn)品文檔: 無相關(guān)文檔


簡單介紹

HTB-38 HT-29 人結(jié)腸癌細(xì)胞,原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種原代細(xì)胞、細(xì)胞系。細(xì)胞庫管理規(guī)范,提供的細(xì)胞株背景清楚,提供參考文獻(xiàn)和培養(yǎng)條件!


HT-29 人結(jié)腸癌細(xì)胞 的詳細(xì)介紹

HTB-38 HT-29 人結(jié)腸癌細(xì)胞
ATCC® Number:  HTB-38?      
Designations:  HT-29 
Depositors:   J Fogh 
Biosafety Level: 1 
Shipped:  frozen 
Medium & Serum:  See Propagation 
Growth Properties: adherent
Organism: Homo sapiens (human) 
Morphology: epithelial

 
Source: Organ: colon
Disease: colorectal adenocarcinoma
Cellular Products: secretory component of IgA; carcinoembryonic antigen (CEA); transforming growth factor beta binding protein; mucin 
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. 
 
Restrictions: The cells are distributed for research purposes only. The Memorial Sloan-Kettering Cancer Center releases the line subject to the following: 1.) The cells or their products must not be distributed to third parties. Commercial interests are the exclusive property of Memorial Sloan-Kettering Cancer Center. 2.) Any proposed commercial use of these cells must first be negotiated with The Director, Office of Industrial Affairs, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; phone (212) 639-6181; FAX (212) 717-3439. 
Isolation:  Isolation date: 1964
Applications: transfection host (Nucleofection technology from Lonza
Roche FuGENE® Transfection Reagents)
Receptors: human adrenergic alpha2A [23560]
urokinase receptor (u-PAR)
vitamin D (moderate expression)
urokinase receptor (u-PAR); vitamin D (moderate expression)
Virus Susceptibility: human immunodeficiency virus (HIV, LAV)
Tumorigenic: Yes 
Oncogene: myc +; ras +; myb +; fos +; sis +; p53 +; abl -; ros -; src - 
Antigen Expression: Blood Type A; Rh+; HLA A1, A3, B12, B17, Cw5
DNA Profile (STR): Amelogenin: X
CSF1PO: 11,12
D13S317: 11,12
D16S539: 11,12
D5S818: 11,12
D7S820: 10
THO1: 6,9
TPOX: 8,9
vWA: 17,19
Cytogenetic Analysis: modal number = 71; range = 68 to 72.
The stemline chromosome number is hypertriploid with the 2S component occurring at 2.4%. Seventeen marker chromosomes are found in most metaphases, generally in single copy per chromosome. The marker designations are: M1p-(=t(3p-;?) with a deleted short arm), t(7q;?), t(10q;?), i(13q), 19q+a; M6, ?t(8q;9q-), ?Xp, M9, 6q+, t(13;?)a, t(13;?)b, 19q+b, M14, M15, 15p+, and Xq-. Chromosome 13 is nullisomic and chromosomes 8 and 14 are generally monosomic. No Y chromosome was detected by QM band analysis.
Isoenzymes:  AK-1, 1
ES-D, 1
G6PD, B
GLO-I, 1-2
Me-2, 1
PGM1, 1-2
PGM3, 1-2
Age:  44 years
Gender:  female 
Ethnicity:  Caucasian 
Comments: Ultrastructural features reported for HT-29 cells include microvilli, microfilaments, large vacuolated mitochondria with dark granules, smooth and rough endoplasmic reticulum with free ribosomes, lipid droplets, few primary and many secondary lysosomes. The cells express urokinase receptors, but do not have detectable plasminogen activator activity [PubMed ID: 8381394]. HT-29 cells are negative for CD4, but there is cell surface expression of galactose ceramide (a possible alternative receptor for HIV). The line is positive for expression of c-myc, K-ras, H-ras, N-ras, Myb, sis and fos oncogenes. The p53 antigen is overproduced, and there is a G -> A mutation in codon 273 of the p53 gene resulting in an Arg -> His substitution. N-myc oncogene expression was not detected.
There is a G -> A mutation in codon 273 of the p53 gene resulting in an Arg -> His substitution.
Propagation:  ATCC complete growth medium: The base medium for this cell line is ATCC-formulated McCoy's 5a Medium Modified, Catalog No. 30-2007. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Subculturing:  Protocol:
Remove and discard culture medium.
Briefly rinse the cell layer with 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.
Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
Add appropriate aliquots of the cell suspension to new culture vessels.
Incubate cultures at 37C.

Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended
Medium Renewal: 2 to 3 times per week
Preservation:  Freeze medium: Complete growth medium, 95%; DMSO, 5%
Storage temperature: liquid nitrogen vapor temperature
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2007
recommended serum:ATCC 30-2020
derivative:ATCC CCL-218
purified DNA:ATCC HTB-38D

產(chǎn)品留言
標(biāo)題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!

聯(lián)系我們
產(chǎn)品搜索

細(xì)胞系,ATCC細(xì)胞,ATCC菌種,細(xì)胞系目錄,ATCC,鼠傷寒沙門氏菌,atcc細(xì)胞庫,人**瘤細(xì)胞,人食管癌細(xì)胞,ATCC 19404,ATCC 25922,ATCC 19146,微生物菌種,細(xì)胞株,標(biāo)準(zhǔn)菌株,ATCC中國,atcc上海代理,CMCC 菌株,ATCC菌株,細(xì)胞目錄,質(zhì)控菌株,腫瘤細(xì)胞株,乳腺癌細(xì)胞系,人肝癌細(xì)胞系

產(chǎn)品目錄

Copyright? 2003-2025  上海復(fù)祥生物科技有限公司版權(quán)所有            電話:021-35080510
傳真:021-35080520    地址:上海市虹口區(qū)赤峰路630號(hào)南雁大廈1901室    郵編: 滬ICP備10013034號(hào)-3  

  

滬公網(wǎng)安備 31010902002429號(hào)